Treatment-related optimism protects quality of life in a phase II clinical trial for metastatic renal cell carcinoma

Annals of Behavioral Medicine

Volumn 42, Issue 3, 2011, Pages 313-320

  Milbury, Kathrin ^a   Tannir, Nizar M ^a   Cohen, Lorenzo ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Clinical trial; Metastatic renal cell cancer; Social support; Treatment related optimism

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; ANTINEOPLASTIC AGENT; RECOMBINANT PROTEIN;

ADULT; AGED; ARTICLE; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; LONGITUDINAL STUDY; MALE; METASTASIS; MIDDLE AGED; PHASE 2 CLINICAL TRIAL (TOPIC); PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOCIAL SUPPORT; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; CLINICAL TRIALS, PHASE II AS TOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERFERON-ALPHA; KIDNEY NEOPLASMS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMBINANT PROTEINS; SOCIAL SUPPORT; TREATMENT OUTCOME;

EID: 84857062914     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12160-011-9301-1     Document Type: Article

References (35)

1. Cella D: Beyond traditional outcomes: Improving quality of life in patients with renal cell carcinoma. Oncologist. 2011, 16 Suppl 2:23-31.
2. Ather MH, Masood N, Siddiqui T: Current management of advanced and metastatic renal cell carcinoma. Urol J. 2010, 7:1-9.
3. Cella D: Quality of life in patients with metastatic renal cell carcinoma: The importance of patient-reported outcomes. Cancer Treat Rev. 2009, 35:733-737.
4. Kirchner H, Strumberg D, Bahl A, Overkamp F: Patient-based strategies for systemic treatment of metastatic renal cell carcinoma. Expert Rev Anticancer Ther. 2010, 10:585-596.
5. Jonasch E, Pagliaro LC, Tannir N. M.: Long-term management of patients with metastatic renal cell carcinoma on targeted agents. Expert Rev Anticancer Ther. 2010, 10:1883-1889.
6. Scheier MF, Carver CS: Dispositional optimism and physcial wellbeing: The influence of generalized outcome expectancies on health. J Pers. 1987, 55:169-210.
7. Segerstrom SC, Taylor SE, Kemeny ME, Fahey JL: Optimism is associated with mood, coping, and immune change in response to stress. J Pers Soc Psychol. 1998, 74:1646-1655. (Pubitemid 128658126)
8. Coyne JC, Tennen H: Positive psychology in cancer care: Bad science, exaggerated claims, and unproven medicine. Ann Behav Med. 2010, 39:16-26.
9. Greer S, Morris T, Pettingale KW, Haybittle JL: Psychological response to breast cancer and 15-year outcome. Lancet. 1990, 335:49-50. (Pubitemid 20020455)
10. Carver CS, Smith RG, Antoni MH, et al.: Optimistic personality and psychosocial well-being during treatment predict psychosocial well-being among long-term survivors of breast cancer. Health Psychol. 2005, 24:508-516. (Pubitemid 41279066)
11. Wimberly SR, Carver CS, Antoni MH: Effects of optimism, interpersonal relationships, and distress on psychosexual wellbeing among women with early stage breast cancer. Psychol Heal. 2008, 23:57-72.
12. Matthews EE, Cook PF: Relationships among optimism, well-being, self-transcendence, coping, and social support in women during treatment for breast cancer. Psychooncology. 2009, 18:716-726.
13. Friedman LC, Kalidas M, Elledge R, et al.: Optimism, social support and psychosocial functioning among women with breast cancer. Psychooncology. 2006, 15:595-603. (Pubitemid 44102745)
14. Cohen L, deMoor, C., Amato, R.J.,: The association between treatment-specific optimism and depressive symptomatology in patients enrolled in a phase I cancer clinical trial. Cancer. 2001, 91:1949-1955. (Pubitemid 32424123)
15. Taylor SE: Adjustment to threatening events-A theory of cognitive adaptation. Am Psychol. 1983, 38:1161-1173.
16. Taylor SE, Armor DA: Positive illusions and coping with adversity. J Pers. 1996, 64:873-898.
17. Stiegelis HE, Hagedoorn M, Sanderman R, et al.: Cognitive adaptation: A comparison of cancer patients and healthy references. Br J Health Psychol. 2003, 8:303-318. (Pubitemid 37158413)
18. Taylor SE, Falke RL, Shoptaw SJ, Lichtman RR: Social support, support groups, and the cancer patient. J Consult Clin Psychol. 1986, 54:608-615. (Pubitemid 17095382)
19. Rosen NO, Knäuper B, DiDio P, Morrison E, Tabing R, Feldstain A, Amsel R, Mayrand MH, Franco EL, Rosberger Z: The impact of intolerance of uncertainty on anxiety after receiving an informational intervention about HPV: A randomised controlled study. Psychol Health. 2010, 25:651-668.
20. Kreitler D, Peleg D, Ehrenfeld M: Stress, self-efficacy and quality of life in cancer patients. Psychooncology. 2007, 16,329-341. (Pubitemid 46681103)
21. Tannir N, Cohen L, Wang X, et al.: Improved tolerability and quality of life with maintained efficacy using twice daily low-dose interferon α-2b. Cancer. 2006, 107,2254-2261.
22. Motzer R, Bacik J, Murphy B, Russo P, Mazumdar R. Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma. J Clin Oncol. 2002,20:289-296. (Pubitemid 34032623)
23. Reed G.M., Kemeny M.E., Taylor S.E., Visscher B.R.: Negative HIV-specific expectations and AIDS-related bereavement as predictors of symptom onset in asymptomatic HIV-positive gay men. Health Psychol. 1999, 18:354-363. (Pubitemid 29343021)
24. Landerman R, George LK, Campbell RT, Blazer DG: Alternative models of the stress buffering hypothesis. Am J Community Psychol. 1989, 17:625-642.
25. Cella DF, Tulsky D, Gray G, et al.: The Functional Assessment of Cancer Therapy Scale: Development and validation of the general measure. J Clin Oncol. 1993, 11:570-579. (Pubitemid 23071057)
26. Cella DF, Zagari MJ, Vandoros C, et al.: Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population. J Clin Oncol. 2003, 2:366-373. (Pubitemid 46606167)
27. Scheier MF, Carver CS, Bridges MW: Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): A reevaluation of the Life Orientation Test. J Pers Soc Psychol. 1994, 67:1063-1078.
28. Singer JD, Willett JB: Applied longitudinal data analysis: Modeling change and event occurrence. New York: Oxford University Press, 2003.
29. Kenn DA KD, Cook WL: Dyadic data analysis. New York: Guilford Press, 2006.
30. Wolfer R, Sang C: Comparing the SAS GLM and MIXED procedures for repeated measures. In: Proceedings of the Twentieth Annual SAS Users Group Conference, Cary, NC. Cary, NC: 1995.
31. Snijders T, Bosker R: Multilevel analysis. Thousand Oaks: Sage, 1999.
32. Preacher KJ, Curran PJ, Bauer DJ: Computational tools for probing interaction effects in multiple linear regression, multilevel modeling, and latent curve analysis. J Educ Behav Stat. 2006, 31:437-448. (Pubitemid 44917080)
33. Taylor SE, Brown JD: Illusion and well-being: A social psychological perspective on mental health. Psychol Bull. 1988, 103:139-210.
34. Thoits PA: Stress, coping, and social support process: Where are we? What next? Journal of Health and Social Behavior. 1995, 35: Extra issue: Forty years of medical sociology: The state of the art and directions for the future.
35. Daugherty C RM, Grochowski E, Stocking C, Kodish E, Mick R, et al.: Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol. 1995, 13(5):1062-1072.